Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma (Q33358646)

From Wikidata
Revision as of 19:17, 22 March 2023 by Reinheitsgebot (talk | contribs) (‎Updated Item: SourceMD author name string resolver script, replacing P2093s with P50s https://bitbucket.org/magnusmanske/sourcemd/src/master/scripts/author_name_strings/bot.py)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma
scientific article

    Statements

    title
    Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    14734456
    retrieved
    26 July 2017
    main subject
    endothelium
    0 references
    author

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q33358646&oldid=1858461266"